Freddy Tinajeros
Population Council
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Freddy Tinajeros.
AIDS | 1998
William C. Levine; Rita Revollo; Veronica Kaune; Juan Vega; Freddy Tinajeros; Marcela Garnica; Miguel Estenssoro; Joel S. Lewis; Giomar Higueras; Raquel Zurita; Linda Wright-De Agüero; Reynaldo Pareja; Patricia Miranda; Raymond L. Ransom; Akbar A. Zaidi; Maria Luisa Melgar; Joel Kuritsky
Objective:To implement an HIV prevention intervention among female commercial sex workers (CSW), and to monitor key outcomes using routinely collected clinical and laboratory data. Design:Cross-sectional and longitudinal analysis of data from an open-enrollment cohort. Setting:One public sexually transmitted disease (STD) clinic and about 25 brothels in La Paz, Bolivia. Participants:A total of 508 female CSW who work at brothels and attend a public STD clinic. Intervention:Improved STD clinical care, supported by periodic laboratory testing, and behavioral interventions performed by a local non-governmental organization. Main outcome measures:Prevalence of gonorrhea, syphilis (reactive plasma reagin titer ≥ 1 : 16), genital ulcer disease, chlamydial infection, and trichomoniasis; self-reported condom use in the previous month; and HIV seroprevalence. Results:From 1992 through 1995, prevalence of gonorrhea among CSW declined from 25.8 to 9.9% (P < 0.001), syphilis from 14.9 to 8.7% (P = 0.02), and genital ulcer disease from 5.7 to 1.3% (P = 0.006); trends in prevalence of chlamydial infection and trichomoniasis were not significant. Self-reported condom use during vaginal sex in the past month increased from 36.3 to 72.5% (P < 0.001). In a multivariate analysis, condom use was inversely associated with gonorrhea [odds ratio (OR), 0.63; 95% confidence interval (CI), 0.41–0.97], syphilis (OR, 0.39; 95% CI, 0.23–0.64), and trichomoniasis (OR, 0.44; 95% CI, 0.32–0.71). In 1995, HIV seroprevalence among CSW was 0.1%. Conclusion:Effective prevention interventions for female CSW can be implemented through public services and non-governmental organizations while HIV rates are still low, and key outcomes can be monitored using data obtained from periodic screening examinations.
Sexually Transmitted Infections | 2006
Freddy Tinajeros; Daniel Grossman; Kara Richmond; Matthew S. Steele; Sandra G. García; Lourdes Zegarra; Rita Revollo
Objective: To evaluate the performance of a point-of-care (POC) syphilis test when used in urban Bolivian maternity hospitals. Methods: We tested 8892 pregnant women for syphilis using the Abbott Determine Syphilis TP rapid POC test and rapid plasma reagin (RPR) in the laboratory of four large urban maternity hospitals where national statistics reported a syphilis prevalence of at least 3%. Sera were stored and transferred to the national reference laboratory (INLASA) where RPR testing was repeated. When the reference laboratory staff observed a positive RPR result, a Treponema pallidum particle agglutination assay (TPPA) was performed to confirm these findings. We calculated test performance characteristics for the POC test and hospital RPR using RPR performed at the reference laboratory confirmed by TPPA as the reference standard. Participants received treatment during their initial visit based on the POC test results. Results: The sensitivity, specificity, negative predictive value and positive predictive values of the POC syphilis test were: 91.8% (95% confidence intervals 88.4% to 94.5%), 98.5% (98.2% to 98.8%), 71.0% (66.6% to 75.2%), and 99.7% (99.5% to 99.8%), respectively. The RPR values were 75.7% (70.8% to 80.2%), 99.0% (98.9% to 99.3%), 76.9% (72.0% to 81.3%), and 99.0% (98.8% to 99.2%), respectively. Conclusion: The Abbott Determine Syphilis TP test proved to be more sensitive than routine RPR and had comparable specificity. POC testing may be a simple way to expand syphilis screening to clinics with no laboratory facilities, improve case detection, and facilitate treatment delivery.
Sexually Transmitted Diseases | 2007
Carol Levin; Matthew S. Steele; Deborah Atherly; Sandra G. García; Freddy Tinajeros; Rita Revollo; Kara Richmond; Claudia Díaz-Olavarrieta; Tom Martin; Florencia Floriano; Isabel Massango; Stephen Gloyd
Objective: The objective of this study was to compare the costs of antenatal syphilis screening with the rapid plasma reagin (RPR) test and the immunochromatographic strip (ICS) test in low-resource settings. Goal: The goal of this study was to assess the costs of introducing rapid syphilis tests to reduce maternal and congenital syphilis. Study Design: Cost data were collected from participating study hospitals and antenatal clinics during 4 field visits to the 2 countries in 2003 and 2004. Health utilization outcome data on the number of women screened and treated routinely during the demonstration projects were used with unit cost data to estimate the incremental costs and average cost per woman screened and treated for maternal syphilis. Results: In Mozambique, the average cost per woman screened was U.S.
Sexually Transmitted Diseases | 2007
Sandra G. García; Freddy Tinajeros; Rita Revollo; Eileen A. Yam; Kara Richmond; Claudia Díaz-Olavarrieta; Daniel Grossman
0.91 and U.S.
Sexually Transmitted Diseases | 2007
Claudia Díaz-Olavarrieta; Sandra G. García; Becca Seitchik Feldman; Alberto Martinez Polis; Rita Revollo; Freddy Tinajeros; David C. Grossman
1.05 for the RPR and ICS tests, respectively. In Bolivia, the average cost of screening was U.S.
Health Care for Women International | 2013
Eileen A. Yam; Freddy Tinajeros; Rita Revollo; Kara Richmond; Deanna Kerrigan; Sandra G. García
1.48 and U.S.
Sexually Transmitted Diseases | 2007
Claudia Diaz-Olavarreita; Sandra G. García; Becca Seitchik Feldman; Alberto Martinez Polis; Rita Revollo; Freddy Tinajeros; Daniel Grossman
1.91 using the RPR and ICS test, respectively. In health centers without laboratories, the cost per woman screened using the ICS test ranged from U.S.
Sexually Transmitted Infections | 2017
Freddy Tinajeros
1.02 in Mozambique to U.S.
Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2017
Freddy Tinajeros; Lucila Rey Ares; Vanessa Elias; Ludovic Reveiz; Franz Sánchez; Martha Mejía; Rosalinda Hernández; Rita Revollo
2.84 in Bolivia. Conclusions: It is feasible to introduce rapid syphilis testing in settings without laboratory services at a small incremental cost per woman screened. In settings with laboratories, the cost of ICS is similar to that of RPR.
Revista Panamericana De Salud Publica-pan American Journal of Public Health | 2017
Freddy Tinajeros; Lucila Rey Ares; Vanessa Elias; Ludovic Reveiz; Franz Sánchez; Martha Mejía; Rosalinda Hernández; Rita Revollo
Objectives: We introduced syphilis immunochromatic strip (ICS) tests into antenatal care (ANC) settings in Bolivia and evaluated feasibility, patient and provider acceptability, and introduction costs. We conducted complementary studies on related topics, strengthened quality of care, and aided the response to sensitive aspects of maternal/congenital syphilis control (e.g., partner notification). Goal: The goal of this study was to discuss our experience working with Bolivian stakeholders to document potential public health benefits of syphilis ICS test introduction in ANC settings. Study Design: We trained public health personnel and offered the Abbott Determine Rapid Syphilis TP test in 4 urban maternity hospitals and 37 rural clinics. Results: Using the ICS test, 11,618 women were tested for syphilis; 5% had positive results and 93.2% received treatment. Women and health personnel found the test acceptable and introduction costs were not prohibitive. Conclusions: Based on these findings, by mid-2006, the Bolivian Ministry of Health will offer the ICS tests in rural ANC settings.